Dr. Lorenza Rimassa

Hepatocarcinoma and cholangiocarcinoma: new treatment for liver tumors

In the past several weeks, Deputy Head of Medical Oncology at Humanitas and Professor of...

Colangiocarcinoma: medical therapies available and in progress

From 10 to 14 April Vienna was the venue for the International Liver Congress, the...

Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also...

In Italy only 10% of the diagnoses of liver cancer occur at an early stage...

EASL 2018: The Role of the Medical Oncologist in the Multidisciplinary Management...

The annual meeting of the European Association for the Study of the Liver (EASL) took...

Hepatocarcinoma: the results of the Humanitas study published in The Lancet Oncology

"Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a...

ASCO 2017: Humanitas Participates to the Congress with an Oral Presentation About...

The yearly meeting of the ASCO (American Society of Clinical Oncology), the main international oncological...